扎鲁司特
登记Id
PA451949
药物名称(英)
zafirlukast
通用名称
zafirlukast
商品名称
Accolate
品牌组合
类型(英)
Drug
类型
药品
交叉引用
"Canadian Drugs Product Database:02236606","ChEBI:CHEBI:10100","Chemical Abstracts Service:107753-78-6","ChemSpider:5515","DrugBank:DB00549","FDA Drug Label at DailyMed:5550433b-8c9c-4378-058f-6bb724c4f18c","KEGG Compound:C07206","KEGG Drug:D00411","National Drug Code Directory:0310-0401-60","PubChem Compound:5717","PubChem Substance:196556","PubChem Substance:46506874","Therapeutic Targets Database:DAP000091","URL:http://en.wikipedia.org/wiki/Zafirlukast"
简化分子线性输入规范
CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC
InChI=1S/C31H33N3O6S/c1-20-8-4-7-11-29(20)41(37,38)33-30(35)22-13-12-21(28(17-22)39-3)16-23-19-34(2)27-15-14-24(18-26(23)27)32-31(36)40-25-9-5-6-10-25/h4,7-8,11-15,17-19,25H,5-6,9-10,16H2,1-3H3,(H,32,36)(H,33,35)
剂量指南
No
外部词汇
"MeSH:C062735(zafirlukast)","ATC:R03DC01(zafirlukast)","UMLS:C0378466(zafirlukast)","RxNorm:114970(zafirlukast)","NDFRT:N0000148457(ZAFIRLUKAST)"
RxNorm 标识符
114970
ATC 标识符
R03DC01
化合物标识符
5717

最新招商产品更多>>

免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:国家药品监督管理局| 国家中医药管理局| SDA药品评审中心| 医加医疗器械| 膏药生产厂家| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:33068302000535
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3